<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>Genetically modified mice are engineered as models for human diseases. These mouse models include inbred strains, mutants, gene knockouts, gene knockins, and ‘humanized’ mice. Each mouse model is engineered to mimic a specific disease based on a theory of the genetic basis of that disease. For example, to test the amyloid theory of Alzheimer’s disease, mice with amyloid precursor protein genes are engineered, and to test the tau theory, mice with tau genes are engineered. This paper discusses the importance of mouse models in basic research, drug discovery, and translational research, and examines the question of how to define the “best” mouse model of a disease. The critiques of animal models and the caveats in translating the results from animal models to the treatment of human disease are discussed. Since many diseases are heritable, multigenic, age-related and experience-dependent, resulting from multiple gene-gene and gene-environment interactions, it will be essential to develop mouse models that reflect these genetic, epigenetic and environmental factors from a developmental perspective. Such models would provide further insight into disease emergence, progression and the ability to model two-hit and multi-hit theories of disease. The summary examines the biotechnology for creating genetically modified mice which reflect these factors and how they might be used to discover new treatments for complex human diseases such as cancers, neurodevelopmental and neurodegenerative diseases.</p>
</abstract>

Genetically modified mice are engineered as models for human diseases. These mouse models include inbred strains, mutants, gene knockouts, gene knockins, and ‘humanized’ mice. Each mouse model is engineered to mimic a specific disease based on a theory of the genetic basis of that disease. For example, to test the amyloid theory of Alzheimer’s disease, mice with amyloid precursor protein genes are engineered, and to test the tau theory, mice with tau genes are engineered. This paper discusses the importance of mouse models in basic research, drug discovery, and translational research, and examines the question of how to define the “best” mouse model of a disease. The critiques of animal models and the caveats in translating the results from animal models to the treatment of human disease are discussed. Since many diseases are heritable, multigenic, age-related and experience-dependent, resulting from multiple gene-gene and gene-environment interactions, it will be essential to develop mouse models that reflect these genetic, epigenetic and environmental factors from a developmental perspective. Such models would provide further insight into disease emergence, progression and the ability to model two-hit and multi-hit theories of disease. The summary examines the biotechnology for creating genetically modified mice which reflect these factors and how they might be used to discover new treatments for complex human diseases such as cancers, neurodevelopmental and neurodegenerative diseases.

Genetically modified mice for research on human diseases: A triumph for Biotechnology or a work in progress?

Department of Psychology and Neuroscience

The EuroBiotech Journal

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Genetically modified mice are engineered as models for human diseases. These mouse models include inbred strains, mutants, gene knockouts, gene knockins, and...

Genetically modified mice for research on human diseases: A triumph for Biotechnology or a work in progress?

Online veröffentlicht: 30. Apr. 2022

Seitenbereich: 61 - 88

DOI: https://doi.org/10.2478/ebtj-2022-0008

Schlüsselwörter
Transgenic, mutant, gene knockout, gene knockin, humanized mice, mouse models, epigenetic, environmental, human diseases, two-hit theories, multi-hit theories

© 2022 Richard E. Brown, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Genetically modified mice for research on human diseases: A triumph for Biotechnology or a work in progress?

Online veröffentlicht: 30. Apr. 2022

Seitenbereich: 61 - 88

DOI: https://doi.org/10.2478/ebtj-2022-0008

SchlüsselwörterTransgenic, mutant, gene knockout, gene knockin, humanized mice, mouse models, epigenetic, environmental, human diseases, two-hit theories, multi-hit theories

© 2022 Richard E. Brown, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Schlüsselwörter
Transgenic, mutant, gene knockout, gene knockin, humanized mice, mouse models, epigenetic, environmental, human diseases, two-hit theories, multi-hit theories